Skip to main content
BEAT logo

HeartBeam, Inc.

BEATNASDAQHealthcareHealth Information Services

$0.43Today:- (-)1Y −75.06%

As of Oct 15, 2026 close

Market cap
$22.77M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.36$4.00
Volume (live)
-
Avg. volume (3M)
14.62M

HeartBeam (BEAT) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), HeartBeam used $13.99M of cash in operating activities and spent $600.00K on capital expenditures. That left free cash flow of −$14.59M.

HeartBeam Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for HeartBeam, Inc. (BEAT) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-21.02-19.45-14.64-12.96-4.43-1.07-0.5442.82-15.96
Depreciation & Amortization0.040.010.000.000.000.000.0040.1728.56
Deferred Income Tax0.000.000.000.000.000.000.00-2.296.05
Stock Based Compensation5.154.303.211.120.190.010.000.007.68
Change in Working Capital1.610.67-0.661.89-1.140.180.0857.8811.10
Change in Accounts Receivable0.000.000.000.000.000.000.00-40.92-19.10
Change in Inventory-0.100.000.000.000.000.000.00-1.990.67
Change in Accounts Payable0.000.43-0.471.530.000.210.003.76-9.62
Change in Other Working Capital1.720.24-0.190.362.16-0.030.0897.0439.15
Other Operating Activities0.230.000.000.002.160.250.24-75.09-13.65
Net Cash from Operating Activities-13.99-14.47-12.09-9.95-3.23-0.60-0.2272.7523.78
Investing Activities
Capital Expenditures-0.60-0.20-0.260.000.000.000.00-24.64-13.70
Purchases of Investments3.760.000.000.000.000.000.000.00-1.32
Sales/Maturities of Investments-3.760.000.000.000.000.000.000.000.00
Other Investing Activities0.000.000.000.000.000.000.00-4.21-162.17
Net Cash from Investing Activities-0.60-0.20-0.260.000.000.000.00-28.85-177.19
Financing Activities
Debt Repayment0.000.000.000.00-0.03-0.020.210.000.00
Common Stock Issued16.590.7324.760.3514.710.000.000.000.00
Other Financing Activities0.000.140.000.000.000.000.000.60166.46
Net Cash from Financing Activities16.590.8724.990.3516.400.620.210.60166.46
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.000.37-0.08
Net Change in Cash2.00-13.8112.65-9.6013.170.02-0.0144.8712.97
Cash at Beginning of Period2.4316.243.5913.190.020.010.0236.0223.05
Cash at End of Period4.442.4316.243.5913.190.020.0180.8936.02
Free Cash Flow-14.59-14.67-12.35-9.95-3.23-0.60-0.2248.1110.09
Supplemental Disclosures
Interest Paid-----0.00---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About HeartBeam Cash Flow

What is HeartBeam's free cash flow?

HeartBeam had negative free cash flow of $14.59M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$13.99M minus $600.00K of capital expenditures.

How much does HeartBeam spend on capital expenditures?

HeartBeam spent $600.00K on capital expenditures in fiscal 2025, compared with $201.00K a year earlier.

Does HeartBeam pay dividends or buy back shares?

HeartBeam's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition